Old Web
English
Sign In
Acemap
>
authorDetail
>
Lingli Zhou
Lingli Zhou
Johns Hopkins University
Neovascularization
Medicine
Triamcinolone acetonide
Dendrimer
Neuroinflammation
4
Papers
11
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
The ancient cardioprotective mechanisms of ACE2 bestow SARS-CoV-2 with a wide host range
2021
bioRxiv
Gianni M Castiglione
Lingli Zhou
Zhenhua Xu
Zachary Neiman
Chien-Fu Hung
Elia J. Duh
Show All
Source
Cite
Save
Citations (1)
Dendrimer‐Triamcinolone Acetonide Reduces Neuroinflammation, Pathological Angiogenesis, and Neuroretinal Dysfunction in Ischemic Retinopathy
2020
Hongkwan Cho
Siva Pramodh Kambhampati
Michael J. Lai
Lingli Zhou
Grace M. Lee
Yangyiran Xie
Qiaoyan Hui
Rangaramanujam M. Kannan
Elia J. Duh
Show All
Source
Cite
Save
Citations (0)
iPSC-derived endothelial cell response to hypoxia via SDF1a/CXCR4 axis facilitates incorporation to revascularize ischemic retina.
2020
JCI insight
Hongkwan Cho
Bria Macklin
Ying-Yu Lin
Lingli Zhou
Michael J. Lai
Grace M. Lee
Sharon Gerecht
Elia J. Duh
Show All
Source
Cite
Save
Citations (10)
Targeted delivery of dendrimer-triamcinolone acetonide modulates neuroinflammation and attenuates neovascularization in oxygen-induced retinopathy
2019
Investigative Ophthalmology & Visual Science
Hongkwan Cho
Siva P. Kambhampati
Michael Lai
Grace M. Lee
Lingli Zhou
Kannan Rangaramanujam
Elia J. Duh
Show All
Source
Cite
Save
Citations (0)
1